Перевести на Переведено сервисом «Яндекс.Перевод»

Mirati Therapeutics Inc.

Link
www.mirati.com
Country
USA
Ticker
NASDAQ:MRTX
Description

Cancer is unique. Cancer is smart. Cancer is specific. Treatment should be too. Mirati is at the forefront of precision medicine — developing genetically-targeted oncology therapeutics for carefully selected groups of patients most likely to benefit from treatment. Mirati’s approach to precision medicine combines three critical factors. Most importantly, Mirati’s drug candidates target specific genetic and epigenetic drivers of cancer. Mirati combines the therapeutic potential of these assets with its creative and agile clinical development strategies focused on identifying and treating patients whose tumors carry the drivers of disease. Finally, this process is led and executed by a highly accomplished precision medicine team, with a track record of bringing breakthrough therapies with accelerated development paths to market.